Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
13.88
-0.04 (-0.29%)
At close: Apr 15, 2025, 4:00 PM
13.84
-0.04 (-0.25%)
After-hours: Apr 15, 2025, 7:55 PM EDT
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $898.63 million as of April 15, 2025. Its market cap has increased by 38.96% in one year.
Market Cap
898.63M
Enterprise Value
700.45M
1-Year Change
38.96%
Ranking
Category
Stock Price
$13.88
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $898.63M, an increase of 43.80%. That is a compound annual growth rate of 18.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2025 | 898.63M | 46.68% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.51B |
| UnitedHealth Group | 534.35B |
| Johnson & Johnson | 370.61B |
| AbbVie | 317.53B |
| Novo Nordisk | 283.15B |
| Abbott Laboratories | 221.71B |
| AstraZeneca | 202.51B |
| Novartis AG | 200.23B |